116 related articles for article (PubMed ID: 7316467)
21. The chromosomes in hematology.
Berger R
Cancer Genet Cytogenet; 1981 Aug; 4(1):69-88. PubMed ID: 7026026
[No Abstract] [Full Text] [Related]
22. Tumorigenicity of human lymphoblastoid cell lines, acquired during in vitro culture and associated with chromosome gains.
Morten JE; Hay JH; Steel CM; Foster ME; De Angelis CL; Busuttil A
Int J Cancer; 1984 Oct; 34(4):463-70. PubMed ID: 6490203
[TBL] [Abstract][Full Text] [Related]
23. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.
Croce CM; Erikson J; ar-Rushdi A; Aden D; Nishikura K
Proc Natl Acad Sci U S A; 1984 May; 81(10):3170-4. PubMed ID: 6328505
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal translocations in leukaemia.
Gauwerky CE; Croce CM
Semin Cancer Biol; 1993 Dec; 4(6):333-40. PubMed ID: 8142618
[TBL] [Abstract][Full Text] [Related]
25. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
26. High frequency of EBV association with non-random abnormalities of the chromosome region 1q21-25 in AIDS-related Burkitt's lymphoma-derived cell lines.
Polito P; Cilia AM; Gloghini A; Cozzi M; Perin T; De Paoli P; Gaidano G; Carbone A
Int J Cancer; 1995 May; 61(3):370-4. PubMed ID: 7729949
[TBL] [Abstract][Full Text] [Related]
27. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
Gaidano G; Ballerini P; Gong JZ; Inghirami G; Neri A; Newcomb EW; Magrath IT; Knowles DM; Dalla-Favera R
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5413-7. PubMed ID: 2052620
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of human leukemias and lymphomas.
Croce CM
AIDS Res Hum Retroviruses; 1987; 3 Suppl 1():229-34. PubMed ID: 3689602
[No Abstract] [Full Text] [Related]
29. Cytogenetic studies on human lymphoblastoid cell lines from Burkitt's lymphomas and other sources.
Jarvis JE; Ball G; Rickison AB; Epstein MA
Int J Cancer; 1974 Dec; 14(6):716-21. PubMed ID: 4377002
[TBL] [Abstract][Full Text] [Related]
30. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
31. Chromosomes and causation of human cancer and leukemia: XXXVI. The 14q+ anomaly in an American Burkitt lymphoma and its value in the definition of lymphoproliferative disorders.
Kakati S; Barcos M; Sandberg AA
Med Pediatr Oncol; 1979; 6(2):121-9. PubMed ID: 460044
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
33. Chromosome translocations and B cell neoplasia.
Croce CM; Tsujimoto Y; Erikson J; Nowell P
Lab Invest; 1984 Sep; 51(3):258-67. PubMed ID: 6433105
[No Abstract] [Full Text] [Related]
34. Abnormal expression of vimentin intermediate filaments in human lymphoid cell lines with deletion or translocation of the distal end of chromosome 8.
Dellagi K; Brouet JC; Portier MM; Lenoir GM
J Natl Cancer Inst; 1984 Jul; 73(1):95-100. PubMed ID: 6204097
[TBL] [Abstract][Full Text] [Related]
35. Isoenzyme studies in human leukemia-lymphoma cell lines--III. beta-Hexosaminidase (E.C. 3.2.1.30).
Drexler HG; Gaedicke G; Minowada J
Leuk Res; 1985; 9(5):549-59. PubMed ID: 3159941
[TBL] [Abstract][Full Text] [Related]
36. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K
J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748
[TBL] [Abstract][Full Text] [Related]
37. Chromosome #14 markers in two Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines of normal origin differ from the Burkitt lymphoma (BL)-associated 14q+ marker.
Manolov G; Manolova Y; Klein G; Levan A; Kieler J
Cancer Genet Cytogenet; 1981 Oct; 4(2):179-84. PubMed ID: 6277469
[TBL] [Abstract][Full Text] [Related]
38. Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells.
Croce CM; Erikson J; Huebner K; Nishikura K
Science; 1985 Mar; 227(4691):1235-8. PubMed ID: 3856319
[TBL] [Abstract][Full Text] [Related]
39. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
40. Characterization of EBV-positive lymphoblastoid cell lines obtained from HIV seropositive patients with or without lymphomas.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Dodi F; Foa R; Rowe M; Ferrarini M
Leukemia; 1992; 6 Suppl 3():12S-14S. PubMed ID: 1318463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
